Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: re3 who wrote (80986)	5/21/2000 12:52:00 PM
From: Knighty Tin	Respond to of 132070

Ike, This is oversimplifying, but the basic difference is that Celera is an assembly line Model T while Incyte, HGSI, etc. are hand made Bentleys. Celera's techniques may prove to be the cheapest way to find effective drugs for simple complaints. INCY and HGSI provide more depth and will be used for more complex problems. In other words, when there is a genetic cure for athletes foot, I expect Celera's techniques will find it. But when there is a genetic cure for Parkinson's Disease, the discoverer is more likely to be Incyte or HGSI.